Jesús María Hernández Rivas-rekin lankidetzan egindako argitalpenak (2)

2016

  1. Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia

    Leukemia Research, Vol. 40, pp. 1-9

2012

  1. Response to imatinib mesylate in patients with hypereosinophilic syndrome

    International Journal of Hematology, Vol. 96, Núm. 3, pp. 320-326